Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy.
Alexandra N de LeoRoi DaganChristopher G MorrisAdam L HoltzmanKathryn E HitchcockCurtis M BryantRobert J AmdurWilliam M MendenhallPublished in: Head & neck (2022)
The addition of concurrent platinum-based chemotherapy to hypofractionated larynx radiotherapy among patients with early-stage glottic SCC with impaired cord mobility appears safe and worthy of additional investigation.